ICU Medical, Inc.
ICUI
$159.58
$2.321.47%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 551.68M | 530.23M | 540.70M | 536.99M | 548.87M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 551.68M | 530.23M | 540.70M | 536.99M | 548.87M |
| Cost of Revenue | 316.63M | 324.00M | 337.72M | 336.11M | 340.80M |
| Gross Profit | 235.05M | 206.23M | 202.99M | 200.88M | 208.06M |
| SG&A Expenses | 151.92M | 154.57M | 155.81M | 152.77M | 159.39M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 491.25M | 499.85M | 514.62M | 510.13M | 522.06M |
| Operating Income | 60.43M | 30.38M | 26.09M | 26.86M | 26.81M |
| Income Before Tax | 26.16M | -4.58M | -18.39M | -4.05M | 36.52M |
| Income Tax Expenses | 7.07M | -34.71M | -2.65M | -658.00K | 1.18M |
| Earnings from Continuing Operations | 19.09M | 30.13M | -15.73M | -3.40M | 35.34M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 19.09M | 30.13M | -15.73M | -3.40M | 35.34M |
| EBIT | 60.43M | 30.38M | 26.09M | 26.86M | 26.81M |
| EBITDA | 110.04M | 80.41M | 76.92M | 77.66M | 76.47M |
| EPS Basic | 0.76 | 1.22 | -0.64 | -0.14 | 1.43 |
| Normalized Basic EPS | 1.20 | 0.31 | 0.12 | 0.19 | 0.28 |
| EPS Diluted | 0.76 | 1.20 | -0.64 | -0.14 | 1.43 |
| Normalized Diluted EPS | 1.20 | 0.31 | 0.12 | 0.19 | 0.28 |
| Average Basic Shares Outstanding | 25.00M | 24.76M | 24.69M | 24.69M | 24.65M |
| Average Diluted Shares Outstanding | 25.04M | 25.18M | 24.69M | 24.69M | 24.71M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |